Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis of fetal alcohol spectrum disorders: German guideline version 2024.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2024
Same author

Guideline registries and libraries: a mixed-methods approach identified issues to be addressed with content.

Journal of clinical epidemiology·2021
Same author

[Short version of the 2nd edition of the German-Austrian S3 guidelines "Cardiogenic shock complicating myocardial infarction-Diagnosis, monitoring and treatment"].

Der Anaesthesist·2020
Same author

Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT).

Bone marrow transplantation·2019
Same author

Surgical therapy of adrenal tumors: guidelines from the German Association of Endocrine Surgeons (CAEK).

Langenbeck's archives of surgery·2019
Same author

Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.

Seminars in arthritis and rheumatism·2019

Related Experiment Video

Updated: Jul 6, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

[Development of national guidelines for depression].

Martin Härter1, C Klesse, I Bermejo

  • 1Abteilung Psychiatrie und Psychotherapie, Sektion Kloinische Epidemiologie und Versorgungsforschung, Universitätsklinikum Freiburg, Hauptstrasse 5, Freiburg, BRD. martin.haerter@uniklinik-freiburg.de

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|March 18, 2008
PubMed
Summary

Depressive disorders are common but treatable. New evidence-based guidelines in Germany aim to improve patient diagnostics and therapy by integrating them into routine healthcare.

Related Experiment Videos

Last Updated: Jul 6, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Area of Science:

  • Psychiatry and Mental Health
  • Clinical Practice Guidelines

Background:

  • Depressive disorders are a leading cause of healthcare consultations and illness globally.
  • Despite advancements, optimizing the diagnosis and treatment of depression remains crucial.
  • Current care for depression requires improvement through structured, evidence-based approaches.

Purpose of the Study:

  • To outline the development of a new evidence-based guideline for depression in Germany.
  • To ensure the guideline's widespread adoption and acceptance among healthcare providers.
  • To facilitate the integration of guideline-recommended diagnostics and treatments into routine clinical practice.

Main Methods:

  • Development of a national evidence-based guideline for depression.
  • Consensus-building among all relevant German healthcare providers.
  • Planning for the dissemination and implementation of the guideline.

Main Results:

  • A comprehensive evidence-based guideline for depression is under development for Germany.
  • A consensus approach is being employed to ensure broad acceptance by healthcare professionals.
  • The guideline aims to standardize and enhance depression care.

Conclusions:

  • Implementing evidence- and consensus-based guidelines is essential for improving depression care.
  • The forthcoming German guideline represents a significant step towards optimizing depression diagnostics and therapy.
  • Integrating guideline-based practices into routine care is a key future objective for managing depressive disorders.